Satake Naoko, Hazama Kyoko, Sono Tamaki, Takahashi Makoto, Ito Junichiro
Department of psychiatry, Kohnodai Hospital, National Center for Global health and Medicine, 1-7-1 Kohnodai, Ichikawa, Chiba, Japan.
Clin Pract Epidemiol Ment Health. 2011 Jan 19;7:1-3. doi: 10.2174/1745017901107010001.
The purpose of the present one-year follow-up study was to describe and investigate the change in the amount of antipsychotic drugs prescribed for ACT (assertive community treatment) clients in Japan. Subjects were 52 clients of ACT from January 2009 to December 2009. Prescription data were collected each month from the time the clients entered into ACT. The results of a Wilcoxon signed-rank test show that the dosage of antipsychotics significantly decreased from 1,131.3 mg to 731.3 mg over the course of the 12 months (Z = -2.505, p = 0.012).
本次为期一年的随访研究旨在描述和调查日本接受积极社区治疗（ACT）的患者所使用抗精神病药物剂量的变化。研究对象为2009年1月至2009年12月期间接受ACT治疗的52名患者。从患者开始接受ACT治疗起，每月收集处方数据。威尔科克森符号秩检验结果显示，在这12个月中，抗精神病药物的剂量从1131.3毫克显著降至731.3毫克（Z = -2.505，p = 0.012）。
